Advanced search
Publication Cover
Current Medical Research and Opinion Volume 29, 2013 - Issue 10
Submit an article Journal homepage
324
Views
12
CrossRef citations to date
0
Altmetric
Allergy: Original article

Efficacy, safety, and optimal dose selection of beclomethasone dipropionate nasal aerosol for seasonal allergic rhinitis in adolescents and adults

Gordon D. RaphaelBethesda Allergy, Asthma and Research Center, LLC Bethesda, MDUSACorrespondence[email protected]
,
William E. BergerUniversity of California Irvine, CAUSA
,
Bruce M. PrennerAllergy Associates Medical Group Inc. San Diego, CAUSA
,
Albert F. Finn JrNational Allergy, Asthma, & Urticaria Centers of Charleston SCUSA
,
Leith KelleyTeva Branded Pharmaceutical Products R&D Inc. Frazer, PAUSA
&
Sudeesh K. TantryTeva Branded Pharmaceutical Products R&D Inc. Frazer, PAUSA
Pages 1329-1340 | Accepted 26 Jun 2013, Published online: 06 Aug 2013

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Monika Marko & Rafał Pawliczak. (2023) Pharmacotherapy and immunotherapy of allergic rhinitis induced by house dust mite, grass, and birch pollen allergens: a meta-analysis of randomized clinical trials. Expert Review of Respiratory Medicine 17:7, pages 607-621.
Read now
Giuliana Ferrante, Laura Montalbano, Giovanna Cilluffo, Velia Malizia, Donatella Marchese & Stefania La Grutta. (2016) Beclomethasone dipropionate hydrofluoroalkane for the treatment of allergic rhinitis. Expert Review of Clinical Immunology 12:3, pages 279-288.
Read now
Lyndon E Mansfield. (2015) Beclomethasone HFA for the treatment of allergic rhinitis. Expert Opinion on Pharmacotherapy 16:18, pages 2849-2857.
Read now
Jamee Castillo & Vesselin Dimov. (2014) Investigational drugs for the treatment of allergic rhinitis. Expert Opinion on Investigational Drugs 23:6, pages 823-836.
Read now

Articles from other publishers (8)

Angela M. Donaldson, Garret Choby, Daniel H. Kim, Lisa A. Marks & Devyani Lal. (2020) Intranasal Corticosteroid Therapy: Systematic Review and Meta‐analysis of Reported Safety and Adverse Effects in Adults. Otolaryngology–Head and Neck Surgery 163:6, pages 1097-1108.
Crossref
Eric L. Wu, William C. Harris, Casey M. Babcock, Bailin H. Alexander, Charles A. Riley & Edward D. McCoul. (2019) Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta‐analysis. Otolaryngology–Head and Neck Surgery 161:1, pages 18-27.
Crossref
Jian Jiao & Luo Zhang. (2019) Influence of Intranasal Drugs on Human Nasal Mucociliary Clearance and Ciliary Beat Frequency. Allergy, Asthma & Immunology Research 11:3, pages 306.
Crossref
A. K. Ellis, D. C. Tsitoura, D. Quint, W. Powley & L. A. Lee. (2017) Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial. Clinical & Experimental Allergy 47:9, pages 1193-1203.
Crossref
Pavol Surda & Wytske J. Fokkens. (2016) Novel, Alternative, and Controversial Therapies of Rhinitis. Immunology and Allergy Clinics of North America 36:2, pages 401-423.
Crossref
Hai Lin, Chunquan Zheng, Jing Li, Chen Yang & Li Hu. (2015) Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway. Scientific Reports 5:1.
Crossref
William E. Berger & Eli O. Meltzer. (2015) Intranasal Spray Medications for Maintenance Therapy of Allergic Rhinitis. American Journal of Rhinology & Allergy 29:4, pages 273-282.
Crossref
Hai Lin, Chunquan Zheng, Jing Li, Chen Yang & Li Hu. (2014) Ca2+-activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis. International Immunopharmacology 23:2, pages 642-648.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.